Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Jaundice in babies linked to gut troubles, new study finds

NCT ID NCT07475624

Knowledge-focused Sponsor: The First Hospital of Jilin University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at over 3,200 newborns with jaundice to find out which ones were more likely to develop digestive problems like feeding issues or stomach bleeding. Researchers reviewed medical records and used special methods to identify risk factors. The goal is to help doctors predict and prevent these complications in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

3,218 people

The number who actually took part.

Started

Dec 2019

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population is a retrospective cohort of neonates hospitalized in the Department of Neonatology at the First Hospital of Jilin University between December 2019 and December 2024. All included neonates were admitted within the first 7 days of life and were diagnosed with neonatal hyperbilirubinemia, defined as having a serum total bilirubin level exceeding the phototherapy threshold for their respective postnatal age and gestational age. This cohort will be analyzed to investigate the risk factors associated with the development of adverse digestive system outcomes.

Ages

1 day to 28 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Neonates admitted to the Department of Neonatology within 7 days after birth. 2. Clinical diagnosis of neonatal jaundice, with a measured serum total bilirubin level exceeding the phototherapy threshold for hyperbilirubinemia. 3. Availability of complete medical records and serum bilirubin test results. 4. Hospitalized at the First Hospital of Jilin University between December 2019 and December 2024. Exclusion Criteria: 1. Major congenital anomalies (e.g., severe gastrointestinal malformations, complex congenital heart disease). 2. Missing essential data for primary outcome or key exposure variables. 3. Length of hospital stay \< 24 hours.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Digestive are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

digestive system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Digestive

Contacts and locations

Locations

  • The First Hospital of Jilin University

    Jilin City, Changchun, 130021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.